For the Quarter Ending June 2026
Cefuroxime Prices in North America
- In USA, the Cefuroxime Price Index rose by 3.27% quarter-over-quarter, driven by higher freight costs.
- The average Cefuroxime price for the quarter was approximately USD 94653.33/MT, reflecting import-dependent landed costs.
- Cefuroxime Spot Price remained tight on thinning distributor inventories and sustained hospital procurement ahead procedures.
- Cefuroxime Price Forecast indicates firmness as exporters factor rising freight, insurance, and energy-driven cost pressures.
- Cefuroxime Production Cost Trend pressured by higher bunker fuel and war-risk surcharges affecting supply logistics.
- Cefuroxime Demand Outlook remains steady with elective surgeries and outpatient prescriptions sustaining baseline consumption channels.
- Cefuroxime Price Index movements reflected competing forces: higher logistics costs versus ample API inflows abroad.
- Exporters absorbed freight spikes to protect contracts, limiting pass-through to invoiced prices and preserving stability.
Why did the price of Cefuroxime change in June 2026 in North America?
- Sharp trans-Pacific freight increases in June raised landed costs, pressuring CFR quotations for importers nationally.
- Origin operating rates remained steady but environmental inspections constrained 7-ACA throughput, tightening export availability modestly.
- Stable domestic demand for surgeries and prescriptions limited price volatility despite logistics-driven cost pressures remaining.
Cefuroxime Prices in APAC
- In China, the Cefuroxime Price Index rose by 3.204% quarter-over-quarter, driven by stronger export demand.
- The average Cefuroxime price for the quarter was approximately USD 94483.33/MT, per FOB Shanghai assessments.
- Cefuroxime Spot Price tightened as exporters timed shipments, reducing exportable surplus ahead of international tenders.
- Cefuroxime Price Forecast suggests modest firmness as exporters balance steady demand with feedstock cost volatility.
- Cefuroxime Production Cost Trend reflects higher solvent recovery tariffs and modest increases in conversion expenses.
- Cefuroxime Demand Outlook improved as India and Brazil replenished inventories, supporting export call-offs during quarter.
- Cefuroxime Price Index stability owed to controlled inventories, run rates, and absent environmental inspection disruptions.
- Exporters may slightly ease FOB offers as importers draw from prior stocks, keeping adjustments controlled.
Why did the price of Cefuroxime change in June 2026 in APAC?
- Export enquiries from India and Brazil reduced exportable inventories, enabling suppliers to lift FOB offers.
- Higher provincial power and solvent recovery tariffs increased variable costs, nudging producers to sustain firmer quotations.
- Geopolitical risk around the Strait of Hormuz threatens solvent supply, lengthening routes and raising freight insurance premiums.
India
- In India, the Cefuroxime Price Index fell by 1.56% quarter-over-quarter, reflecting marginal cost and demand shifts.
- Export enquiries and stable plant operations kept the Cefuroxime Spot Price supported despite mild input cost pressures.
Cefuroxime Prices in Europe
- In Germany, the Cefuroxime Price Index rose by 3.23% quarter-over-quarter, driven by firmer Asian offers.
- The average Cefuroxime price for the quarter was approximately USD 94,626.67/MT, reported on CFR Hamburg delivery terms.
- Cefuroxime Spot Price strengthened as buyers replenished pipelines, tightening short-term availability amid conservative seller offers.
- Cefuroxime Price Forecast shows moderate near-term firmness reflecting upstream cost pass-through and steady downstream consumption.
- Cefuroxime Production Cost Trend rose due to higher steam and solvent costs plus environmental audit surcharges.
- Cefuroxime Demand Outlook remains stable with hospital tenders and routine outpatient prescriptions supporting baseline pharmaceutical offtake.
- Cefuroxime Price Index momentum supported by precautionary German buying and exporters cautiously reflecting energy-linked freight premiums.
- Inventory draws tightened spot availability as intermittent rail disruptions and Euro depreciation influenced landed costs.
Why did the price of Cefuroxime change in June 2026 in Europe?
- Higher Asian export offers and steam-solvent cost inflation transmitted to Hamburg, tightening supply and lifting prices.
- Euro depreciation increased dollar-denominated import invoices, raising landed costs despite physically adequate Asian shipments and port operations.
- German buyers replenished inventories ahead of summer logistics slowdowns and hospital tenders, supporting marginal upward price pressure.
For the Quarter Ending March 2026
Cefuroxime Prices in North America
- In the USA, the Cefuroxime Price Index fell by 2.01% quarter-over-quarter, reflecting abundant imports recently.
- The average Cefuroxime price for the quarter was approximately USD 91658.33/MT, reflecting softer import costs.
- Cefuroxime Spot Price remained range-bound as distributors drew from comfortable inventories, limiting spot buying pressure currently.
- Cefuroxime Price Forecast shows monthly variability, modest firmer bias as freight and audits raise costs.
- Cefuroxime Production Cost Trend reflects higher logistics and compliance expenses, increasing delivered-cost pressure for importers.
- Cefuroxime Demand Outlook is stable across hospitals and retail, tenders and utilization limit upside pressure.
- Cefuroxime Price Index firmed in March as freight spikes and tighter compliant output contracted volumes modestly.
- Exports from China and India remained intact, exporters balanced offers protecting margins amid US demand.
Why did the price of Cefuroxime change in March 2026 in North America?
- March freight increases raised landed costs, prompting exporters to pass higher logistics charges to buyers.
- Environmental inspections limited surplus 7-ACA output, tightening delivered supply and reducing distributors' buffer inventories slightly.
- Stable hospital procurement and tenders restrained spot buying, moderating downward price pressure despite cost rises.
Cefuroxime Prices in APAC
- In China, the Cefuroxime Price Index fell by 1.97% quarter-over-quarter, reflecting modest bearish pressure overall.
- The average Cefuroxime price for the quarter was approximately USD 91550.00/MT across FOB export offers.
- Cefuroxime Spot Price remained range-bound as exporters held offers amid ample inventories and operating rates.
- Cefuroxime Price Forecast indicates mild recovery as downstream formulators replenish ahead of second-quarter production schedules.
- Cefuroxime Production Cost Trend stayed flat with stable feedstock and energy tariffs, limiting cost pressure.
- Cefuroxime Demand Outlook improved modestly in March driven by hospital tenders and export replenishment from markets.
- Cefuroxime Price Index reflected monthly variation as routine logistics and no environmental shutdowns maintained consistent supply.
- Port activity and inventory management kept export flows steady, constraining volatility despite regional procurement seasonality.
Why did the price of Cefuroxime change in March 2026 in APAC?
- Hospital tender finalizations supported demand, absorbing exportable volumes and lifting realized FOB offers modestly in March.
- Stable feedstock and unchanged energy tariffs prevented production-cost inflation, maintaining producer margins and price stability.
- Normal port operations and three-week inventories reduced logistics disruption risk, encouraging systematic replenishment by buyers.
Cefuroxime Prices in Europe
- In Germany, the Cefuroxime Price Index fell by 1.95% quarter-over-quarter, reflecting ample Asian export availability.
- The average Cefuroxime price for the quarter was approximately USD 91663.33/MT, supporting modest seller resistance.
- Ample Asian flows pressured the Cefuroxime Spot Price, keeping Hamburg landed values soft to offers.
- The Cefuroxime Price Forecast shows modest strengthening as buyers cautiously rebuild inventories for hospital tenders.
- Elevated freight and energy influenced the Cefuroxime Production Cost Trend, constraining exporters' margin recovery mildly.
- Stable hospital contracts and stewardship limits define the Cefuroxime Demand Outlook, keeping incremental buying subdued.
- Inventory cushions and Asian exports restrained the Cefuroxime Price Index, limiting seller leverage in negotiations.
- Logistics delays and early tender calls tightened availability, prompting spot premiums and firmer March CFRs.
Why did the price of Cefuroxime change in March 2026 in Europe?
- Reduced Asian run-rates, diverted plant capacity tightened arrivals, creating immediate supply pressure and spot premiums.
- A firmer euro softened dollar-denominated offers in euro terms, offsetting headline cost increases for importers.
- Extended transit times and isolated rail disruptions increased urgency for replenishment, elevating demand, CFR quotes.
For the Quarter Ending December 2025
Cefuroxime Prices in North America
- In USA, the Cefuroxime Price Index rose by 1.04% quarter-over-quarter, reflecting marginal import cost increases.
- The average Cefuroxime price for the quarter was approximately USD 131855.00/MT, reflecting landed-cost change modestly.
- Stable imports kept the Cefuroxime Spot Price steady while margins tracked Cefuroxime Production Cost Trend.
- Cefuroxime Price Forecast shows narrow ranges as freight reductions offset modest upstream input firmness recently.
- Seasonal restocking supports the Cefuroxime Demand Outlook and keeps the Cefuroxime Price Index broadly steady.
- Inventory remained moderate at wholesalers, limiting upside for Cefuroxime Spot Price despite importer allocations currently.
- Export supply discipline from Asia and FDA oversight stabilized volumes, supporting the Cefuroxime Price Index.
- Manufacturers and importers expect measured procurement, aligning with the Cefuroxime Price Forecast and stable demand.
Why did the price of Cefuroxime change in December 2025 in North America?
- Reduced Trans-Pacific freight and steady Asian API exports lowered landed costs, tempering upward pressure seasonally.
- Chinese environmental inspections trimmed some export offers while West Coast port operations preserved arrivals timely.
- Hospital restocking and GPO pricing caps balanced procurement, sustaining marginal price increases without triggering volatility.
Cefuroxime Prices in APAC
- In China, the Cefuroxime Price Index rose by 1.5% quarter-over-quarter, supported by export procurement demand.
- The average Cefuroxime price for the quarter was approximately USD 132333.33/MT, reflecting export and domestic contracts.
- Cefuroxime Spot Price remained pressured in December as ample export-oriented supply slightly outpaced incremental overseas enquiry.
- Cefuroxime Price Forecast signals narrow, mildly soft trading into early quarter absent significant demand improvement.
- Cefuroxime Production Cost Trend was stable as 7-ACA availability and energy tariffs exerted minimal upward pressure.
- Cefuroxime Demand Outlook remains steady with hospital tender caps limiting domestic upside while supporting exports.
- Cefuroxime Price Index showed marginal quarterly gain while inventories rose and exporters trimmed offers defensively.
- Major Chinese plants maintained sub-seventy percent operating rates, constraining volatility while keeping export supply adequate.
Why did the price of Cefuroxime change in December 2025 in APAC?
- Exports outpaced incremental enquiries in December, creating mild oversupply pressure on FOB quotations and offers.
- Stable 7-ACA feedstock and unchanged energy tariffs limited production cost increases, reducing upward price momentum.
- Port operations remained fluid and currency movements provided no advantage, prompting exporters to concede discounts.
Cefuroxime Prices in Europe
- In Germany, the Cefuroxime Price Index rose by 1.47% quarter-over-quarter, reflecting marginal import cost increases.
- The average Cefuroxime price for the quarter was approximately USD 132418.33/MT, according to trade statistics.
- Cefuroxime Spot Price remained muted in December due to moderate inventories and reduced spot buying.
- Cefuroxime Price Forecast indicates range-bound near-term pricing, contingent on logistics and stewardship-driven hospital procurement patterns.
- Cefuroxime Production Cost Trend rose from higher 7-ACA and energy-related compliance costs, pressuring export offers.
- Cefuroxime Demand Outlook remains seasonally supportive from hospital tenders while stewardship protocols limit volume growth.
- Cefuroxime Price Index reflected import-cost pass-through, freight uplifts and comfortable inventories, preventing upward pricing moves.
- Asian exporters maintained operating rates, prioritised US orders, narrowing German availability and supporting CFR Hamburg.
Why did the price of Cefuroxime change in December 2025 in Europe?
- Balanced import flows and unchanged Asian offers kept landed costs stable, limiting December price pressure.
- Hospital purchasers covered fourth-quarter needs, reducing spot inquiries and weakening sellers' demand for higher premiums.
- Freight and logistics eased in Hamburg, while comfortable wholesaler stocks reduced urgency, nudging prices lower.
For the Quarter Ending September 2025
North America
- In USA, the Cefuroxime Price Index fell by 3.56% quarter-over-quarter, reflecting exporter discounting and inventory.
- The average Cefuroxime price for the quarter was approximately USD 130496.67/MT, reflecting elevated landed costs.
- Cefuroxime Spot Price softened as US buyers reduced orders, leaving elevated inventories and strained liquidity.
- Cefuroxime Price Forecast points to volatility, with potential stabilization as replenishment increases and inventories normalize.
- Cefuroxime Production Cost Trend eased due to lower upstream input prices, supporting exporter margin recovery.
- Cefuroxime Demand Outlook remains steady, anchored by hospital and clinical usage despite conservative pharmaceutical procurement.
- Freight rate declines and episodic congestion created landed cost signals, supporting the Cefuroxime Price Index.
- Scheduled maintenance and seasonal procurement could tighten supply briefly, mildly lifting the Cefuroxime Price Index.
Why did the price of Cefuroxime change in September 2025 in North America?
- Oversupply from major Asian exporters pressured discounts, increasing US inventories and sustaining downward price pressure.
- Falling freight rates followed by port congestion created inconsistent landed costs, confusing importer procurement decisions.
- Buyer caution amid tariff uncertainties and high inventories suppressed spot demand, limiting upward price momentum.
APAC
- In China, the Cefuroxime Price Index fell by 3.47% quarter-over-quarter, driven by oversupply and weak demand.
- The average Cefuroxime price for the quarter was approximately USD 130400.00/MT, reflecting subdued domestic demand.
- Cefuroxime Spot Price rallied briefly during operational disruptions, yet overall Price Index remained subdued amid inventory overhang.
- Cefuroxime Production Cost Trend shows downward pressure from cheaper raw materials, partly offset by elevated logistics expenses.
- Cefuroxime Demand Outlook remains weak as PMI contraction and export tariffs suppressed new orders and downstream offtake.
- Cefuroxime Price Forecast suggests modest volatility with intermittent upticks due to maintenance and occasional forward buying.
- High inventories and tariff-driven export disruptions pressured domestic margins, influencing the Cefuroxime Price Index trajectory negatively.
- Major producer maintenance temporarily tightened supply, but smaller manufacturers increased volumes, keeping spot markets and Price Index soft.
Why did the price of Cefuroxime change in September 2025 in APAC?
- Temporary plant maintenance reduced available exports while domestic inventories remained elevated, creating mixed supply signals.
- Logistics disruptions and port congestion increased distribution costs, contributing to localized tighter supply and upward price pressure.
- Weak pharmaceutical demand, PMI contraction and high inventories suppressed selling prices despite periodic forward buying and short-term restocking.
Europe
- In Germany, the Cefuroxime Price Index fell by 3.51% quarter-over-quarter, driven by ample inventories nationally.
- The average Cefuroxime price for the quarter was approximately USD 130503.67/MT, according to reported data.
- Cefuroxime Spot Price volatility eased as German distributors prioritized inventory liquidation, compressing Price Index movements.
- Cefuroxime Production Cost Trend softened amid lower energy and input costs, supporting margins for manufacturers.
- Cefuroxime Demand Outlook for hospitals remained subdued, with buyers exercising cautious procurement and prioritizing inventories.
- Cefuroxime Price Forecast indicates modest near-term weakness, with slight recovery potential as logistics gradually normalize.
- Elevated inventories and muted export demand kept the Cefuroxime Price Index anchored despite logistical pressures.
- Chinese supply remained ample, while producers offered discounted volumes, exerting downward pressure on spot markets.
Why did the price of Cefuroxime change in September 2025 in Europe?
- Persistent inventory overhang from earlier procurement waves reduced spot purchases, pressuring prices downward in September.
- Shipping delays and elevated logistics costs supported prices, but delayed peak surcharges limited import-driven spikes.
- Subdued downstream demand and cautious procurement strategies by hospitals and manufacturers constrained upward price momentum.
